Home - Products - Others - Other Targets - AU-224

AU-224

CAS No. 287399-47-7

AU-224( —— )

Catalog No. M33244 CAS No. 287399-47-7

AU-224 is an orally available benzamide derivative that is a potent gastrointestinal prokinetic.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	411	In Stock
10MG	562	In Stock
25MG	866	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

AU-224
Note

Research use only, not for human use.
Brief Description

AU-224 is an orally available benzamide derivative that is a potent gastrointestinal prokinetic.
Description

AU-224 is a benzamide derivative used as a promising gastrointestinal prokinetic agent without significant side effects.
In Vitro

——
In Vivo

AU-224 has excellent effect of promoting digestive motion while showing little side effect and can be orally administered. AU-224 shows only weak gastrointestinal prokinetic activity after oral administration due to its low lipophilicity.
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

287399-47-7
Formula Weight

397.9
Molecular Formula

C19H28ClN3O4
Purity

>98% (HPLC)
Solubility

——
SMILES

O=C(OCCCC)CN1CCC(NC(=O)C=2C=C(Cl)C(N)=CC2OC)CC1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. WO/2000/046201A1

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Crocetin methylester

Crocetin monomethyl ester (Standard) is the analytical standard of Crocetin monomethyl ester. This product is intended for research and analytical applications. Crocetin monomethyl ester, isolated from Crocus sativus, possesses anti-inflammatory, neuroprotective and antioxidant activity. Crocetin monomethyl ester promotes clearance of amyloid-β by inducing autophagy via the STK11/LKB1-mediated AMPK pathway.
JI130

JI130 is able to impair the ability of Hes1 to repress transcription. JI130 treatment significantly reduced tumor volume in a murine pancreatic tumor xenograft model.
SJ000291942

SJ000291942 is an activator of the canonical bone morphogenetic proteins (BMP) signaling pathway.

Sign In Join Free